Forensic Urine Drug Testing Laboratories often requires two confirmatory methods for a methamphetamine positive screen. First, methamphetamine is identified and quantitated using gas chromatography-mass spectrometry. If the total methampbetamine concentration is above the administrative cutoff level, the isomeric composition must be determined. This eliminates a possible contribution by over-the-counter cold medications that contain t-methamphetamine (Vick's | inhalers). Products that contain only the/-isomer of methamphetamine must be distinguishable from prescription or illicitly manufactured methamphetamine, which consists mainly of the d-isomer. Optically impure derivatizing reagents will produce an impure mixture from a pure isomeric compound. Therefore, methods utilizing impure reagents can prove problematic when interpreting results. Use of an optically pure chiral derivatizing reagent, such as R(-)-~c-methoxy-atrifluoromethylphenylacetic acid chloride, allows for the creation and measurement of chromatographically separable isomeric compounds. The novel method described here utilizes a polymer-based solid-phase column adapted to a positive pressure manifold extraction system and a one-step derivatization process that occurs directly in the elution solvent. This methodology eliminates an elution solvent dry-down step that may adversely affect recovery of volatile amphetamine compounds. Although the method was designed for the quantitative analysis of the isomers of amphetamine and methamphetamine, it can be adapted for use with a wide range of phenethylamines including methylenedioxyamphetamine, N-methylenedioxymethamphetamine, and possibly N-methylenedioxyethylamphetamine. The linear range for quantitation was 25-10,000 ng/mL for d,l-methamphetamine and d,l-amphetamine, and correlation coefficients were 0.997 or better. The coefficient of variation for all four analytes did not * Author to whom correspondence should be addressed. E-mail: justin.holler@afip.osd.mil. exceed 2.8%. Concentrations analyzed ranged from 500 to 4000 ng/mL (n = 40). The method allows for a simple and accurate quantitation and isomeric determination of amphetamine and methamphelamine using a process that eliminates extraction and derivalization complications common in current methods.
Introduction
Extraction and derivatization of volatile amines in forensic urine drug testing is a common and often laborious process. Several methodologies have been used to limit the loss of these compounds during extraction and purification from urine (1) (2) (3) (4) (5) (6) . Commonly, high boiling point solvents (NjV-dimethylformamide) have been used to trap compounds before the eluate is evaporated to dryness. Salt formation has also been employed because salts of these compounds display much less volatility than the free bases. Development of methodology that allows processing of urine specimens suspected to contain volatile amines, without employing the additional steps mentioned to prevent volatilization, would be a beneficial addition to the current methodologies used by the forensic urine drug testing laboratories. The use of a nonprotic solvent, like triethylamine, enables analysis of volatile amines without the necessity of salt formation of the compounds. It provides the basic medium required for solid-phase extraction in addition to enhancing amine derivatization, which occurs directly in the elution solvent. Acetone, another nonprotic solvent, is used to augment the elution of target compounds, and, unlike methanol or isopropanol, it also enhances derivatization. Both methanol and isopropanol have weakly acidic hydroxyl groups that interfere with the derivatization reaction.
Amphetamine is a psychoactive stimulant that was first marketed in the 1930s as an over-the-counter inhaler for the treatment of nasal congestion and for allergy symptoms. The pharmacological effects consist of stimulatory cardiovascular effects, a strong increase in mental and physical stamina, and drug-seeking behavior when abused. Amphetamine is a moderate to strong stimulant that increases wakefulness and enhances performance, and as a result, it is popular with individuals who desire increased endurance beyond their normal limits. Currently, amphetamine is available by prescription for narcolepsy, attention deficit hyperactivity disorder (ADHD), and as a dietary supplement for appetite suppression. Single isomer forms of d-amphetamine are available as Dexedrine | Adderall | is also prescribed and contains salt forms of both d-and/-amphetamine (7, 8) .
Methamphetamine is the more potent methylated derivative of amphetamine. Although it is still prescribed in its d-isomeric form as Desoxyn | illicit methamphetamine is clandestinely synthesized and widely abused in the United States. The /-isomeric form of methamphetamine is the active ingredient of Vick's inhalers and other nasal decongestants because it exhibits vasoconstrictive affects without the euphoria associated with the d-isomer. Illicit forms of methamphetamine will consist of either all d-methamphetamine or a racemic mixture depending on the method of synthesis (7) . Clandestine manufacture of methamphetamine from the reduction of (-)ephedrine or (+)pseudoephedrine yields d-methamphetamine, whereas the production of methamphetamine from phenyl-2-propanone (P2P) and methylamine yields a racemic mixture (7) .
Methamphetamine is metabolically converted to amphetamine with maintenance of the isomeric composition of the starting compound (7) . To determine if a positive urine drug confirmation for amphetamine/methamphetamine is caused by illicit use of the d-isomer or legal nonprescription use of the/-isomer, an analytical procedure must be available to determine the isomer composition (9, 10) . A common approach is use of a chiral derivatizing reagent in order to produce chromatographically separable isomeric compounds. A problem commonly encountered during chiral derivatization is the appearance of an impurity in an optically pure analyte because of the optical impurity of the derivatizing reagent (11, 12) . By selecting an optically pure reagent such as R-(-)-(~-methoxy-c~-trifluoromethylphenylacetic acid chloride (R-MTPAC), the isomers present can be chromatographically separated and quantitated while maintaining the isomeric composition of the starting compounds. No racemization has been observed when using R-MTPAC (13, 14) .
The Department of Defense (DoD) drug-testing program requires all military urine samples be screened by immunoassay for amphetamine/methamphetamine and designer amphetamines methylenedioxymethamphetamine (MDMA), methylenedioxyamphetamine (MDA), and methylenedioxyethylamphetamine (MDEA). Current military protocol following a positive amphetamine/methamphetamine urine immunoassay screen is to quantitate the amphetamine/ methamphetamine concentration by gas chromatographymass spectroscopy (GC-MS) in selected-ion-monitoring mode (SIM). DoD guidelines state that for GC-MS, a minimum of three ions must be monitored for the target analyte and two for the internal standard. In addition, there are minimum criteria for the acceptance of retention times, peak shapes, and signalto-noise ratios before a sample can be reported as positive (15) . If quantitation is greater than or equal to 500 ng/mL for methamphetamine, a separate extraction using chiral derivatization must be performed. The current derivatizing reagent used for this chiral determination is (S)-(-)-N-trifluoroacetylprolyl chloride [(S)-TPC]. Because of the chiral impurity of (S)-TPC, optically impure derivative analytes can occur (11, 12) . Therefore, urine positive methamphetamine results are only reported when the concentration is at or above 500 ng/mL with a d-isomeric composition greater than 20% of the total. Currently, the DoD does not perform isomeric analysis for samples that confirm positive for amphetamine only.
By using an optically pure derivatizing reagent, such as R-MTPAC, a single extraction can be performed to quantitate both isomers of amphetamine and methamphetamine in addition to determining the percentage of each. This method will alleviate the need for a second extraction and conserve time and sample while providing both an accurate urine drug concentration in addition to the isomeric composition of the amphetamine/methamphetamine ingested.
Experimental

Chemicals and reagents
All solvents were HPLC grade and were purchased from
l-methamphetamine, and d,l-metham-
phetamine-dn were purchased from Cerilliant (Round Rock, TX). R-MTPAC (> 99.5% purity) was purchased from Fluka (Switzerland) and triethylamine was purchased from Aldrich (Milwaukee, WI). CEREX | POLY.CROM TM CLIN II (691-0506) solid-phase extraction columns were obtained from SPEware Corporation (San Pedro, CA).
Sample preparation and extraction
Urine samples (2 mL) were prepared by the addition of I mL of 100mM phosphate buffer (pH 6.0). Three-milliliter Clin II columns were labeled and placed in a SYSTEM-48 TM positive pressure manifold. Samples were then transferred onto the columns, and pressure was applied to give a slow, steady flow (< 1 psi of N2). Following sample application, the columns were washed sequentially with 1 mL of deionized water, 1 mL of 0.1M acetic acid, I mL of methanol, and 1 mL of ethyl acetate. The columns were dried under 25 psi of nitrogen for 3-5 rain. Analytes were eluted with 2 mL of methylene chloride/acetone/triethylamine (79:20:0.5).
Derivatization
Derivatization was performed by the addition of 50 IJL of R-MTPAC solution (100 IJL of R-MTPAC in 2 mL of dry acetonitrile) directly to the eluates without evaporation, followed by incubation at 60-70~ for 15 rain. Once derivatization was complete, 100 IlL of anhydrous ethanol was added to the eluates and incubated at 60-70~ for 15 min. The ethanol reacts with the excess derivatizing agent to minimize column degradation. The eluates were evaporated to dryness under nitrogen at 50~ before being reconstituted with 50 uL of ethyl acetate.
Instrumental analysis
Urine samples were analyzed for the amphetamine and methamphetamine isomers using an Agilent Technologies 6890 GC coupled to a 5973 MS (Palo Alto, CA). One-microliter split- Time (rain) less injections were made with the injector temperature held at 140~ The separation column was a J&W DB-5MS (20 m x 0.18-ram i.d. x 0.18 mm, Rancho Cordova, CA) with helium carrier gas maintained at a constant flow of 1.0 mL/min. An initial oven temperature of 140~ was held for a half minute before ramping to 215~ at 15~ and then to 285~ at 35~
The column was held at the final temperature for I min for a total run time of 10.0 min. The transfer line temperature was set to 280~ The SIM ions for each analyte and internal standard were (* denotes quantitation 
Results and Discussion
Chromatography
The d and l isomers of amphetamine were separated by 0.21 rain, and the d and l isomers of methamphetamine were separated by 0.07 min. Figure I shows the total ion chromatogram (TIC) of a 100 ng/mL calibrator. Figure 2 shows the extracted ion chromatograms of each isomer and their respective deuterated internal standards. Chromatographic peaks sharing similar ions are resolved, allowing the integration and processing of data to occur without ion ratio failures.
The peak shapes were sharp and symmetrical throughout the linear concentration range. An interference peak was observed at higher concentrations of amphetamine for the 130 ion of the amphetamine-d11. This peak is caused by amphetamine and can be separated by manipulation of GC-MS parameters to achieve baseline resolution.
MS
The molecular ions of amphetamine-MTPA (m/z 351) and methamphetamine-MTPA (m/z 365) were not observed. As seen with most phenethylamines, extensive fragmentation occurs during electron ionization at 70eV. Ion selection was the most important aspect of improving the chromatography, reproducibility, and linear response of the method. The highest deuterium substituted internal standard available was chosen to insure that each fragment would contain some isotopic distinction from its parent compound. Deuterated internal standards can have the same fragmentation ions as the target compounds thus increasing the likelihood of ion contributions and ratio failures. This is most evident at lower parent concentrations as internal standards are added at fixed concentrations. At the lower analyte concentrations, the ion contribution from the deuterated internal standard comprises a greater proportion, relative to the non-deuterated target ion, causing ion ratios to fall outside the acceptable range of + 20%. Conversely, at the higher parent concentrations, fragmentation from the non-deuterated target compound could potentially contribute to the deuterated internal standard ion abundance producing a decrease in the quantitated values for the target analyte. It is for these reasons that careful and deliberate consideration was given to the selection of the monitored ions. The ability to chromatographically resolve fragments generated by the internal standard from fragments derived from the target compound alleviated most problems associated with ion ratio failures producing a notable increase in the linear range of the method.
tinearity
Multi-point calibration curves (N = 9) were constructed by plotting the target compound and internal standard peak-area ratios versus the concentration. A weighted (l/x) linear regression line was generated for d,l-amphetamine and d,l-methamphetamine over a concentration range of 25--10,000 ng/mL. The method exhibited linearity with correlation coefficients (R 2) of 0.999, 0.997, 0.999, and 0.999 for d-amphetamine, d-methamphetamine,/-amphetamine, and l-methamphetamine, respectively. The limit of detection (LOD), the lowest concentration of drug where all ion ratios are acceptable, though the observed quantitation may be outside the + 20% range of the theoretical, for the assay was 10 ng/mL for all analytes.
Selectivity
Certified drug-free urine from six separate sources were analyzed for the presence of matrix interferences, none were detected. Numerous compounds, both structurally similar and non similar, were extracted and analyzed for possible co-elution and ion contribution effects. The listed compounds in Table I were spiked into 2.0 mL of certified drug-free urine at a concentration of 50,000 ng/rnL. The d,l-amphetamine and d,lmethamphetamine were spiked at 125 ng/mL. In addition, ephedrine and pseudoephedrine were spiked at a concentration of 500,000 ng/mL with no interference observed. Of the compounds listed in Table I , three were found to cause interference using the procedure. Phentermine and phenethylamine were the only compounds that both co-eluted and caused ion ratio failures. Phentermine has fragmentation ions of rn/z 118 and 130, which interfere with quantitation of both d,l-amphetamine. Phenethylamine has a fragmentation ion of m/z 118, which contributed to the overall abundance of the m/z 118 ion of d-amphetamine, thus causing an ion ratio failure. The compounds were spiked into urine containing d,l-amphetamine, d,l-methamphetamine, and analyzed using (S)-TPC derivatization, the method currently used by the DoD and many civilian drug testing laboratories, to see if a similar problem occurred. Interference was observed following this extraction method as well suggesting that analysis employing (S)-TPC as the derivative has similar liabilities relative to the MTPA derivative. Amitriptyline, a common antidepressant, chromatographically co-eluted and caused an ion ratio failure for /-amphetamine; however, the concentration was well above the expected therapeutic range. A 10-fold dilution of the amitriptyline sample exhibited no interference or ion contribution.
Recovery
The calculated recovery percentage was based on the area ratio response of the quantitation ion of an unextracted standard versus an extracted sample. The recovery was measured in duplicate at 125 nglmL and 1250 ng/mL. The recovery percentages were 99.2%, 104.6%, 95.6%, and 95.3% for/-amphetamine, d-amphetamine, l-methamphetamine, and d-methamphetamine, respectively.
Precision
Precision was calculated for both amphetamine and methamphetamine at three concentrations: 500, 2000, and 4000 ng/mL. Each concentration contained isomeric compositions for the d-isomers of each compound: 10, 25, 50, and 75%. The mean concentrations, the coefficients of variance (CV), and the standard deviations were recorded for each sample. Between-day precision was measured over 10 extractions with CVs ranging from 0.4 to 7.2% for d,l-amphetamine and from 0.5 to 4.0% for d,l-methamphetamine. No ion ratio failures were observed.
Within-day precision consisted of five aliquots of each con- 1.7% for d,l-amphetamine and 0.1--4.7% for d,l-rnetham- phetamine. No ion ratio failures were observed.
Accuracy
Accuracy was determined by dividing the group mean by the theoretical target concentration and was expressed as a percent difference. Calculations were based on the total amphetamine and methamphetamine concentrations at three levels: 500, 2000, and 4000 ng/rnL with 40 replicates at each concentration. A summary of the overall method accuracy is summarized in Table II . The percent differences range from 0.2 to 6.4% and from 2.1 to 3.5% for amphetamine and methamphetamine, respectively. The CV did not exceed 2.8% for either analyte over the three concentrations.
Conclusions
The determination of amphetamine/methamphetamine concentration along with the isomeric composition is necessary in determining if a positive urine analysis result is due to over-thecounter, prescription, or illicit, drug use. Adoption of the proposed analytical method will alleviate the necessity of two separate extractions, currently in practice at most forensic laboratories. Historically, in the DoD drug-testing program, the d-isomer of methamphetamine must be greater than or equal to 20% of the total, to be considered a positive result. One reason for this policy was impurities and instabilities inherent in the (S)-TPC derivatizing reagent, which could potentially cause racemization in optically pure compounds. The optically pure R-MTPAC reagent has been shown to eliminate this racemization. Therefore, if analysis determines the d-isomer of a compound is present in a sample, it can be reasonably concluded that the d-isomer was ingested while at the same time discounting the possibility of the/-isomer being converted to the d-isomer during sample analysis.
The amphetamine class of drugs are highly volatile compounds. This becomes apparent when eluates from a solidphase extraction are evaporated to complete dryness at 55~ Under these conditions, significant amounts of amphetamine and methamphetamine may be lost to volatilization. This problem can be addressed by lower dry down temperatures, incomplete evaporation, or by producing amphetamine/methamphetamine hydrochloride salts by the addition of methanolic HCi. The method described here eliminates losses of these compounds by derivatizing directly into the elution solvent. IYiethylamine is used in the elution solvent, in place of the commonly used ammonium hydroxide, as it will not react with the derivatizing reagent, but will provide the basic medium for extraction of the amphetamines class of compounds from the extraction columns. Additionally, the presence of reactive ammonium hydroxide may interact with the derivatizing reagent resulting in incomplete derivatization and low yields. Triethylamine, a nonprotic elution solvent, is preferentially used in place of ammonium hydroxide for ion exchange interactions. This compound will provide the basic medium required for elution of the amphetamine class of compounds. In addition, triethylamine eliminates possible interaction of ammonium hydroxide with the derivatizing reagent, which could potentially result in incomplete derivatization and low yields. Triethylamine has the added benefit of acting as an acid "scavenger" for the hydrochloric acid produced by the substitution reaction during derivatization. Triethylamine neutralization of the acid formed will inhibit amphetamine/methamphetamine salt formarion leading to increased sensitivity, lower levels of detection, and enhanced baseline resolution. A fast, simple, and robust solid-phase extraction of urine specimens followed by chiral derivatization and GC--MS analysis was developed for amphetamine/methamphetamine analysis. The method may also be used for any amine where extraction from a biological matrix is required. The reported method allows for quantitation and isomer analysis using a single extraction in addition to reducing, the amount of specimen consumed for analysis, the amount of amphetamine/methamphetamine lost because of unnecessary manipulation, as well as improve turn around time for positive specimens.
